bioAffinity Technologies, Inc.

BIAF Healthcare Diagnostics & Research

In the quarter to June 2026, revenue grew 19.0%, EPS grew 87.5%, free cash flow fell 23.7% and total debt rose 569.7%, each against the same quarter a year earlier.

3.73 0.23 −5.81%
Market cap
$5.1M
P/E
0.0×
Fwd P/E
−0.2×
Dividend yield
—
F-score
2/9
Altman Z
−10.54
Beneish M
−5.49
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.72 3.04 0.33 0.47
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(1.33) (5.34) (0.79) (1.27)
P/B ratio
1.13 4.70 0.28 0.35
Price to Tangible BV
2.53 11.08 0.39 0.47
EV/Sales
0.40 2.60 (0.61) (0.64)
EV/EBITDA
0.00 0.00 0.37 0.44
EV/Operating CF
(0.21) (1.35) 0.40 0.51
EV/FCF
(0.21) (1.35) 0.40 0.51
Quick Ratio
1.24 1.19 2.41 3.44
Current Ratio
1.44 1.36 2.60 3.65
Net Debt/EBITDA
0.57 0.71 1.92 3.44
Debt/Assets
7.28% 7.74% 6.20% 1.58%
Debt/Equity
0.15 0.17 0.09 0.02
Asset Turnover
0.95 0.84 0.71 0.75
Operating CF/Net income
0.95 0.89 0.82 0.49
Capex/Depreciation
(1.46) (0.05) 0.00 0.03
Interest Coverage
(285.03) (246.05) (239.47) (424.59)
Research and Development Expense of Revenue
55.44% 50.59% 41.99% 32.77%
Selling, General and Administrative Expense of Revenue
189.24% 239.85% 190.68% 152.78%
Intangible Assets out of Total Assets
0.27 0.27 0.19 0.19
Share Based Compensation of Revenue
51.97% 1.06% 4.15% 4.65%
Graham Net Nets
0.00 0.00 1.91 1.89
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(898.56%) (307.03%) (1,334.92%) (707.62%)
Free Cash Flow Yield
(272.26%) (63.46%) (462.09%) (269.48%)
Revenue per Share
4.33 4.51 13.87 20.34
Operating CF per Share
(9.18) (10.76) (22.30) (34.88)
Capex per Share
(0.26) (0.02) 0.00 0.05
Free Cash Flow per Share
(9.44) (10.78) (22.30) (34.83)
Cash per Share
6.97 10.33 56.18 107.87
Shareholders Equity per Share
10.81 12.21 63.39 125.21
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
10.81 12.21 63.39 125.21
Free Cash Flow
(3.29) (3.23) (2.56) (2.48)
Working Capital
1.18 1.16 4.66 6.25
Capital Expenditures
(0.09) (0.01) 0.00 0.00
Net Current Asset Value
0.01 0.06 3.88 5.97
EV/EBIT
0.00 0.00 0.35 0.42
Capex to Sales
0.06 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
0.66 0.82 0.84 0.89
Average Payables
1.07 1.11 0.87 0.86
Average Inventory
0.06 0.06 0.04 0.03
Average Assets
6.19 6.75 8.74 9.05
Average Common Equity
0.82 2.55 4.94 6.01

Fold the line items

Columns are period end dates · fundamentals updated 2 Oct 2026